A nine-test system using multiple-inoculation agar plates for biotyping of Escherichia coli is described. Testing of 959 strains resulted in 78 biotypes. On repeated testing, 96% of 182 strains had identical biotypes or differed by only one test. This system provides satisfactory differentiation among strains and is reproducible. Precise standardization of inoculum size is not required. Multiple inoculation allows time and cost-efficient testing of large numbers of strains.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC273151 | PMC |
| http://dx.doi.org/10.1128/jcm.10.3.275-278.1979 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Prevalence and Molecular Epidemiology of Intestinal Colonization by Multidrug-Resistant Bacteria among Hematopoietic Stem-Cell Transplantation Recipients: A Bulgarian Single-Center Study.
Antibiotics (Basel)
September 2024
Clinical Microbiology Laboratory, University Hospital "St. Marina"-Varna, 9010 Varna, Bulgaria.
Article Synopsis
- The study investigates the rate of intestinal colonization by multidrug-resistant (MDR) bacteria in post-hematopoietic stem-cell transplant (HSCT) patients at a hospital in Varna, Bulgaria, from 2019 to 2021.
- Out of 74 patients, 37.8% were found to have MDR bacteria, with the majority being Gram-negative, particularly ESBL-producing and carbapenem-resistant strains.
- Molecular techniques were employed to analyze resistance mechanisms, revealing key beta-lactam resistance genes and a clonal relationship among certain bacterial isolates.
Evaluating the accuracy of the MBT Lipid Xtract Kit for assessing colistin resistance in comparison to broth microdilution.
J Med Microbiol
September 2024
Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Colistin resistance testing methods such as broth microdilution (BMD) are time-consuming and labour intensive for clinical laboratories. MBT Lipid Xtract Kit on MALDI Biotyper Sirius System (Bruker, Billerica, MA, USA) utilizes lipidomic analysis to identify specific cell wall modifications associated with colistin resistance. We compared MBT to BMD (ComASP Colistin, Liofilchem) across 36 Gram-negative isolates (non-resistant MIC ≤2 µg ml, resistant MIC ≥4 µg ml).
View Article and Find Full Text PDFMALDI glycotyping of O-antigens from a single colony of gram-negative bacteria.
Sci Rep
June 2024
Laboratory of Advanced Chemical Biology, Graduate School of Life Science, Hokkaido University, Sapporo, 001-0021, Japan.
Polypeptide-targeted MALDI-TOF MS for microbial species identification has revolutionized microbiology. However, no practical MALDI-TOF MS identification method for O-antigen polysaccharides, a major indicator for epidemiological classification within a species of gram-negative bacteria, is available. We describe a simple MALDI glycotyping method for O-antigens that simultaneously identifies the molecular mass of the repeating units and the monosaccharide composition of the O-antigen.
View Article and Find Full Text PDFLipidomic approach to identify Escherichia coli and Shigella spp. by matrix-assisted laser desorption/ionization mass spectrometry.
Adv Med Sci
September 2024
Centre for Modern Interdisciplinary Technologies, Nicolaus Copernicus University, Wileńska 4 Str, Toruń, 87-100, Poland. Electronic address:
Purpose: Escherichia coli (E. coli) and Shigella species, being highly similar, present a challenge for differentiation using classical methods such as phenotyping, 16S rRNA sequencing, or protein profiling using matrix-assisted laser desorption/ionization mass spectrometry (MALDI MS). The paper proposes a method for identifying E.
View Article and Find Full Text PDFEvolution of ceftazidime-avibactam and cefiderocol resistance in ST131-H30R1- isolates with KPC-3 mutants and application of FTIR biotyping.
Microbiol Spectr
April 2024
Servicio de Microbiología, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.
Ceftazidime-avibactam and cefiderocol represent two of the few alternatives for infections by KPC-producing Enterobacterales. We reported the emergence of resistance to both ceftazidime-avibactam and cefiderocol in a KPC-producing ST131- (KPC-ST131-) clinical isolate. Antimicrobial susceptibility testing, Fourier-transform infrared (FTIR) spectroscopy, whole-genome sequencing, and cloning experiments were performed.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!